Cello Health PLC (LSE:CLL) - Share price - Overview

Stock Report

Cello Health PLC CLL

Last Price
GBX123.00

Day Change
2.00|1.65%

As of 24/05/2018
17:08:01 BST | GBX
Minimum 15 Minutes Delay.

Last Close121.00p
Day Range121.75 - 123.00
Mkt Cap126.60Mil
52-Wk Range106.67 - 138.40
Yield %2.80
ISINGB00B0310763
Volume37,541
P/E14.75
P/S0.01
P/CF0.47

Share Price

Total Returns 23/05/2018

 Chg (%)  
More ...
Cello Health PLC3.31 
FTSE 100 TR GBP4.50
 
Financials
201520162017
More ...
Income Statement
Turnover156.74165.27169.29
Operating Profit9.087.8112.85
Net Profit3.32-2.514.23
Reported EPS3.76-2.864.03
Balance Sheet
Current Assets48.9354.3367.54
Non Current Assets77.5573.9878.07
Total Assets126.48128.30145.61
Current Liabilities44.6849.1949.89
Total Liabilities55.6761.7562.74
Total Equity70.8266.5582.87
Cash Flow
Operating Cash Flow8.256.514.79
Net Change in Cash-0.481.765.87

Regulatory News

DateSourceHeadline
More ...
09/05/2018|13:14RNSCello Health PLC - Result of AGM
09/05/2018|07:00RNSCello Health PLC - AGM Statement
30/04/2018|14:58RNSCello Health PLC - Total Voting Rights
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
27/09/2017SaleMr. Mark Bentley127.50110,000140,250.00
27/09/2017PurchaseMr. Mark Bentley127.53110,000140,283.00
22/09/2017Exercise of OptionMr. Mark Bentley10.00255,00025,500.00
22/09/2017Sale of OptionMr. Mark Bentley126.50150,450190,319.00

Company Profile

Cello Health PLC with its subsidiary company provides market research and direct communications services to its consumer. Its segments include Cello Health and Cello Signal.

Sector

Marketing Services

Index

FTSE AIM All-Share

Next Event 20/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)30.02
Div Yld (E)2.85
PEG (E)0.00
ROCE6.45
Op Mrgn0.08
EPS Grwth26.83
Dividends
PreviousLatest
More ...
Record Date05/05/1706/10/17
Ex-Div04/05/1705/10/17
Paid26/05/1703/11/17
Amnt2.401.05
Directors
More ...
Executive Director, Finance Director and Company SecretaryMr. Mark Bentley
Executive Director, Chief ExecutiveMr. Mark Coleridge Scott
Executive Director, Group Corporate Development DirectorMr. Stephen Highley
Non-Executive Director, ChairmanMr. Allan Jeffrey Rich
Non-Executive DirectorMr. Paul Richard Hamilton
Non-Executive DirectorMr. William Nigel David
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.